definiens: shall mean the date upon which [ * * ] has [ * * ], but in no eventlater than [ * * ] . The transfer price for QS-21 supplied by [COMPANY] shall be in accordance with the QS-21 supply transferpricing mechanism based on a [ * * ] of [ * * ] of the Fully Burdened Costs, provided that in the event that [COMPANY] hasmore than one QS-21 manufacturing facility ( itself or through a Third Party ), then for purposes of determining theFully Burdened Costs of QS-21 manufacture by [COMPANY], the Fully Burdened Cost components shall not exceed theaverage of such costs among the various facilities, and provided further that in no event shall the Fully BurdenedCost components exclusive of the manufacturing direct labor and direct material costs exceed [ * * ] . [COMPANY] shall keepAntigenics informed as to its timelines for having commercial grade QS-21 manufacturing capabilities . In additionand without limiting the foregoing, the Parties shall meet quarterly starting [ * * ] to discuss [COMPANY] ’s progress, developments, and timelines with respect to QS-21 manufacturing to ensure that [COMPANY] will meet the Capacity Datedeadline of [ * * ] . In such meetings, [COMPANY] shall provide [COMPANY] with detailed summaries and updates with respectto the foregoing . In the event that [COMPANY] determines that there is a possibility that it will not be able to supply QS-21to [COMPANY] by [ * * ], or thereafter have an inability to supply [COMPANY] with quantities requested by [COMPANY], [COMPANY] shall immediately notify [COMPANY] and cooperate with [COMPANY] to address such inability